MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Randomize study of occurrence of Parkinson’s syndrome in patients with rheumatoid arthritis.

    M. Mavlanov, S. Aslanova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: We aimed to study an occurrence of Parkinson’s syndrome (PS), its relationship with duration of disease and age of patients with rheumatoid arthritis. Background:…
  • 2017 International Congress

    Association of nocturnal stridor with clinical features of patients with multiple system atrophy

    H.-S. Ryu, J.-H. Paek, S. You, M.-J. Kim, Y.J. Kim, J. Kim, K. Kim, S.-A. Lee, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association between findings of night video-polysomnography and clinical feature of patients with multiple system atrophy (MSA). Background: Nocturnal sleep-related clinical sympotoms…
  • 2017 International Congress

    [11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study

    P. Vazquez Rodriguez, J. Rowe, J. O'Brien, F. Aigbirhio, T. Fryer, L. Su, E. Mak, A. Surendranathan, R. Borchert, S. Jones, R. Arnold, R. Bevan-Jones, L. Passamonti, Y. Hong (Cambridge, United Kingdom)

    Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…
  • 2017 International Congress

    To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population

    M. Modi, R. Shree, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)

    Objective: To study the role of serum DJ-1 and Apo A1 in the diagnosis and differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes(PPS)…
  • 2017 International Congress

    The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease

    T. Yamamoto, M. Asahina, Y. Yamanaka, T. Uchiyama, S. Hirano, M. Fuse, Y. Koga, R. Sakakibara, S. Kuwabara (Chiba, Japan)

    Objective:  To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…
  • 2017 International Congress

    Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy

    Y. Compta, F. Antonelli, M. Fernandez, P. Bravo, M. Soto, A. Camara, D.M. Giraldo, M.J. Marti, On-behalf-of Catalan-MSA-Registry Group (Barcelona, Spain)

    Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…
  • 2017 International Congress

    Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy

    W. Meissner, F. Bassil, P. Guerin, N. Dutheil, Q. Li, M. Klugmann, E. Bezard, P.-O. Fernagut (Bordeaux, France)

    Objective: We aimed to develop AAV-based models of MSA Background: Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by a combination of autonomic…
  • 2017 International Congress

    The predictor factors for survival in Chinese Multiple System Atrophy patients

    B. Cao, L. Zhang, Y. Zou, Q. Wei, R. Ou, Y. Chen, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: Our aim was to explore the predictors of survival in Chinese multiple system atrophy (MSA) patients. Background: MSA is a rare, fatal neurodegenerative disorder with…
  • 2017 International Congress

    Depression, anxiety and quality of life in Multiple System Atrophy

    L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…
  • 2017 International Congress

    α-Synuclein Preformed Fibrils Induce Disruption of Myelin Basic Protein Expression in Primary Oligodendrocyte Culture; Deciphering Glial Pathology in Multiple System Atrophy

    S. Kaji, T. Maki, N. Uemura, R. Takahashi (Kyoto, Japan)

    Objective: This research focuses on the impact of extracellular α-synuclein preformed fibrils (α-syn PFFs) on oligodendrocytes (OLGs) as a potential contributor exacerbating the pathology of…
  • « Previous Page
  • 1
  • …
  • 1390
  • 1391
  • 1392
  • 1393
  • 1394
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley